US 8658691
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
granted A61KA61K31/40A61P
Quick answer
US patent 8658691 (Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound) held by Theravance, Inc. expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/40, A61P, A61P1/00, A61P1/10